Quinoxaline chemistry: Part 10. Quinoxaline 10-oxa-analogues of trimetrexate (TMQ) and of 5,8-dideazafolic acid. Synthesis and evaluation of in vitro anticancer activity

Farmaco

Volumn 53, Issue 2, 1998, Pages 150-159

  Vitale, Gabriella ^a   Corona, Paola ^a   Loriga, Mario ^a   Paglietti, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

5,8 Dideazafolic acid analogues; Anticancer agents; Quinoxaline derivatives; Trimetrexate analogues

Indexed keywords

5,8 DIDEAZAFOLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; GLUTAMIC ACID DERIVATIVE; QUINOXALINE DERIVATIVE; TRIMETREXATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; HUMANS; QUINAZOLINES; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIMETREXATE; TUMOR CELLS, CULTURED;

EID: 0032453977     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00003-2     Document Type: Article

References (12)

1. M. Loriga, G. Vitale, G. Paglietti, Quinoxaline chemistry. Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity, Farmaco 53 (1998) 139-149.
2. M. Loriga, M. Fiore, P. Sanna, G. Paglietti, Quinoxaline chemistry. Part 4. 2-(R)-anilinoquinoxalines as non classical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity, Farmaco 50 (1995) 289-301.
3. M. Loriga, M. Fiore, P. Sanna, G. Paglietti, Quinoxaline chemistry. Part 5. 2-(R)-Benzylaminoquinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity, Farmaco 51 (1996) 559-568.
4. M. Loriga, M. Piras, P. Sanna, G. Paglietti, Quinoxaline chemistry. Part 7. 2-[Aminobenzoates]- and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity, Farmaco 52 (1997) 157-166.
5. M. Loriga, P.A. Moro, P. Sanna, G. Paglietti, Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity, Farmaco 52 (1997) 531-537.
6. J.E. Oatis Jr., J.B. Hynes Jr., Synthesis of quinazoline analogues of folic acid modified at position 10, J. Med. Chem. 20 (1977) 1393-1396.
7. J.B. Hynes, S.A. Patil, R.L. Hagan, A. Cole. W. Kohler, J.H. Freisheim, Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts, J. Med. Chem. 32 (1989) 852-856.
8. W.T. Mueller, G.K. Smith, S.J. Benkovic, J.B. Hynes, Inhibition of chicken liver 5-aminoimidazole-4-carboxamide ribonucleotide transformylase by 5,8-dideaza analogues of folic acid, Biochem. Pharmacol. 37 (1988) 449.
9. F.H.S. Curd, D.G. Davey, G.J. Stacey, Synthetic antimalarials. Part XL. The effect of variation of substituents in 2-chloro-3-β-diethylaminoethylaminoquinoxaline, J. Chem. Soc. (1949) 1271-1277.
10. E.I. Fairburn, B.J. Magerlein, L. Stubberfield, E. Stapert, D.I. Weisblat, Oxygen analogs of pteroic acid, J. Am. Chem. Soc. 76 (1954) 676-679.
11. M.R. Boyd, Status of the NCI preclinical antitumor drug discovery screen, Princ. Pract. Oncol. 3 (10) (1989) 1-12.
12. D.W. Weislow, R. Kiser, D. Fine, J. Bader, R.H. Shoemaker, M.R. Boyd, New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS antiviral activity, J. Natl. Cancer Inst. 81 (1989) 577-586.